Stockreport

BioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint [Yahoo! Finance]

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
PDF US$6.15 loss per share (further deteriorated from US$5.92 loss in FY 2022). BTAI Products In Clinical Trials Phase I: 2. Phase III: 2. All figures shown in the [Read more]